Abstract Event-related potentials and reaction time measures to auditory discrimination tasks ofgraded difficulty were used to separate cognitive from motor processing time in 27 patients with newly diagnosed, previously untreated Parkinson's disease and later on optimal levodopa treatment. Before treatment eventrelated potential P3 and task performance were normal but the reaction time was prolonged compared with age matched controls. After treatment P3 latency was significantly prolonged and the reaction time reduced suggesting a dopamine induced dissociation between cognitive and motor processing. In early Parkinson's disease cognitive processing time remains normal but the motor processing time is prolonged. Dopamine replacement is followed by significantly reduced motor processing time despite increased cognitive processing time. Motor processing may reflect the dopamine status of the putamen whereas dopaminergic over-stimulation of other regions may adversely affect cognitive processing in patients treated with levodopa.
Parkinson's disease (PD) was originally considered to be a motor disorder without any impairment of mental function' but evidence23 is growing that some cognitive decline does occur although it is not clear whether this relates to basal ganglia pathology or cortical involvement.4 Some patients show specific focal cognitive deficits such as difficulties in strategy shifting,5 pattern tracking,6 and memory scanning,7 whilst others exhibit a general cognitive impairment.8 Performance IQ has been shown2 to be impaired compared with verbal IQ but this may be due to motor deficits confounding assessment of performance. There is no "pathognomonic" cognitive profile for patients with idiopathic PD. Levodopa treatment initially improves psychometric performance9 but prolonged treatment is associated with deterioration. '0 Planning of movements is considered a major defect in movement control in PD." Reaction time experiments'2 support this view although Rafal et al '3 found no evidence that bradykinesia is accompanied by slowness in assembling a motor programme but slowing in the later stages could not be ruled out. It is difficult on psychological testing to separate cognitive from motor processing stages. This is particularly so in PD with the invariable presence of motor disability confounding evaluation of cognitive processing time.
The cerebral potentials associated with information processing, especially the timing of sensory stimulus discrimination and categorisation together with the reaction time measures, provide a unique means of separating decision processes from motor involvement. These event-related potentials (ERP) are insensitive to physical characteristics of the stimulus but are primarily affected by the task associated with stimulus discrimination which requires the subject to distinguish a particular target stimulus from a randomly presented sequence of two or more different types of stimuli. This paradigm yields an ERP complex comprising components NI, N2 and P3. NI, a negative potential occurring around 100 ms after simulus onset is considered to represent the encoding of the auditory stimulus.'4 N2 is a second negative peak occurring aroung 200 ms after stimulus which may represent the input stage of the stimulus evaluation process (see Discussion). P3, a positive potential with respect to the pre-stimulus baseline with a modal latency of 300 ms reflects motor-free speed of cognitive processing. P3 latency increases with advancing age and with the difficulty of target identification. 5 After it had been shown that P3 is significantly delayed in patients with dementia, '6 Hansch et al 7 demonstrated a prolongation of P3 latency in patients with PD treated with levodopa (Sinemet). O'Donnell et al 8 showed further that increase in P3 latency correlated with mental status decline. In contrast, Goodin and Aminoff " observed no difference in P3 latency in non-demented, treated PD patients whereas PD patients with dementia showed a significant delay of NI and P3. The discrepancy with the earlier studies'7 18 was considered due to the mix of demented and non-demented patients. No study has considered the effect of drug therapy although in a recent study20 of only seven patients with severe motor fluctuations, a significant decrement in P3 latency was shown in the "on" phase. The purpose of this study was to evaluate whether the speed of cognitive processing, as measured by P3, is slower in an unselected group of newly diagnosed, non-demented patients with PD and by combining performance measures, and reaction time determine which stages of information processing are most affected especially for levodopa treat- Subjects were tested on two auditory tasks of graded difficulty as it was considered that the harder task may reveal subtle cognitive abnormalities. Task 1: Frequency discrimination: 1-5 kHz vs 1-0 kHz. A random series of high and low pitch tones of 100 ms duration were presented in a ratio of 30/70 and the subject identified by pressing a response button the high pitch target tone. Task 2: Duration Discrimination: 200 ms vs 100 ms at 1 0 kHz. In this task the subject identified the shorter tone burst presented randomly in the same target/ non-target ratio. The order of presentation of the two tasks was randomised across subjects.
Subjects were presented 100 stimuli per test at 60 dBHL binaurally through TDH39 headphones at a rate of 0 3 Hz and were instructed to respond to the target as quickly as possible. Reaction time (RT) for correctly identified targets was measured to the nearest millisecond. Performance in terms of the number of targets correctly classified, missed and wrongly classified was assessed. On the basis of the control group performance a total of five or more targets missed or wrongly classified constituted impairment of performance. A preliminary run ensured that each subject understood the requirements of the task and was familiar with the target tone burst.
The cerebral potentials were recorded using standard silver/silver chloride EEG electrodes from mid-frontal (Fz), mid central (Cz) and mid-parietal (Pz) electrode placements on the scalp (according to the international 10:20 system) with reference to linked mastoids. Electrode impedence was reduced by skin abrasion to below 2 k ohms. This response activity was filtered so that the 3dB cut offpoints were 0 03 Hz and 32 Hz with a slope of 6 db/ octave. Signals were amplified 50 000 times and averaged separately according to target and non-target stimuli. The analysis window was 768 ms duration sampled every 1 ms. Patients and subjects were instructed to relax when performing the tasks avoiding any movement other than the button press in relation to the stimulus and were observed throughout the procedure for any overt orienting or stimulus related movements including any excessive or stimulus locked blinking but none was noted. However, any trials with large (> 50 uV) artifactual excursions were automatically excluded by the computer from entering the average. The cerebral potential averages were independent of the patients' responses in that the error trials were not excluded from the averages. Only those trials in which the error was one of omission of overt response were included in the Target average as the subject may have classified the stimulus accurately but may have made a slow response which fell outside the response capture window of one second. Errors of commission were included in the Non-Target average. Furthermore, the total number of errors was computed and its relationship to P3 latency analysed. The data were averaged on-line using an HP 9836 computer with a Transera data acquisition system. The ERP component peaks of interest were N1, N2 and P3 which were identified from the three electrode sites but the statistical latency comparisons were made for those measured from the Pz electrode position. In the case of a double peaked P3, P3a and P3b, the measurement of P3b was taken for computation. In the case of a flatter component the method of Goodin et al 6 was adopted in that the leading and trailing slopes of the peak in the window of 280-600 ms were extrapolated and the point of their intersection was taken as the P3 latency.
Results
Comparison of the ERP component latencies and reaction time recorded initially from untreated PD patients and age matched controls, shown in table 1, revealed no significant differences in the mean latencies ofcomponents NI, N2, P3 or the mean RT for the frequency discrimination task. For the duration task the mean latency of N2 for PD was slightly prolonged compared to the control group although statistically falling outside the 5% significance level (p = 0-052). Mean P3 latency was not significantly different but the RT was (p = 00 16) prolonged compared with controls. The number ofpatients with significantly prolonged P3 latency beyond the normal 2SD limit are shown in fig 3. For some patients a delayed P3 on one task did not mean a delay on the other task. RT was prolonged beyond the 2SD normal limit in two patients for the frequency task and six for the duration task although only one of these patients had an absent P3 on the duration task, the others had a normal P3.
The classification errors were generally fairly small as indicated by the median figures although there was a certain skewness to the distribution as shown by the figures in table 2. The Mann-Whitney test showed no significant difference in the error scores between controls and patients. Of the 27 patients, three made more than five errors in target classification for the frequency task and six for the duration task. Only one of these patients had a delayed P3 and another prolonged RT whilst for the rest, the deterioration in performance did not appear to affect P3 or RT.
There were five patients who had focal or global impairment on psychometric assessment and their mean latency of P3 and RT did not differ significantly from the others with normal psychometry. the legend which indicate a general improvement in RT but a somewhat variable performance. Performance was measured in terms of the total number of errors which constituted missed targets and incorrect classification of non-targets. As there was no significant difference in the missed and wrongly classified non-targets as a function of treatment, further comparisons were made for the total error score. The correlation of P3 latency and RT with the error score revealed that increasing number of errors did not affect the latency of P3 or RT directly. Patients with a large number of errors did not necessarily have a prolonged P3 latency. A statistical comparison of performance between controls and patients before and after treatment shows no significant difference in either case (table 2) . However, P3 latency is significantly prolonged after treatment despite any difference in the error scores as a result of treatment.
In an attempt to establish whether the change in P3 following therapy was due to progression of the disease over the treatment period (mean time 47 weeks) or the effect of dopaminergic treatment itself, the difference in latency before and after treatment was correlated with treatment duration. For ease of comparison the patients were divided into those having treatment for less than 30 weeks (with a mean of 14 weeks) and those more than 30 weeks (with a mean of 82 weeks). The former consisted of 15 patients and the latter 12 with no difference in their mean ages. The effect of treatment period on P3 and RT for both tasks is summarised in table 3 which shows that the mean change in P3 latency for the duration task for the group treated for a mean period of 14 weeks is significantly (p < 0 02) smaller (22 ms) compared to the group treated for a mean period of 82 weeks (58 ms). However, there was no effect of treatment period on the mean change in P3 latency for the frequency task and RT for both tasks.
Discussion
Only patients with early Parkinson's disease were examined and most had a normal neuropsychological assessment (22/27) Starkstein et al20 reported a decrease in the latency of P3 without any change in RT in the "on" phase compared to the "off" in patients with fluctuating PD. Such apparent variation in the results from this study may relate to the differences in treatment and stages of the disease. Furthermore, the on/off situation is physiologically very different from that of this study.
Although the precise psychological correlate of P3 is not clear it is generally considered to cover stimulus evaluation stages of information processing whereas RT includes this as well as response selection and execution. From the comparison of RT and P3 it is evident that the stimulus and response stages are differentially affected by treatment. Prolongation of RT before treatment and its improvement on levodopa is in accord with a number of studies3233 of choice reaction time which have either reported normal RT or improvement in RT after levodopa treatment. In contrast, sim- In a similar fashion to SRT and CRT, P3 and RT are unlikely to follow a sequential process along a continuum, being differentially affected by treatment, they may indeed be mediated via separate parallel pathways. Prasher 
